Xenon Pharmaceuticals Inc.

XENE · Healthcare

$60.00

Markedsværdi: 5.81B USDUdbytteafkast: —
AdvancedEr det et godt tidspunkt at købe Xenon Pharmaceuticals Inc.? Spørg Copenvest AIFå et Advanced AI-bud på timing, risiko og hvad tracked investorer gør.Spørg Copenvest AI

Indlæser diagram…

Nyheder

Seneste overskrifter for denne aktie

Insider Monkey4. sep. 2026, 19.06

Xenon (XENE) Heads To Europe With Data That Could Reshape Epilepsy Care

GlobeNewswire3. sep. 2026, 20.01

Xenon to Present at Wells Fargo Healthcare Conference

Business Wire31. aug. 2026, 14.49

BIOTECanada Announces 2026 Gold Leaf Award Winners, Recognizing Excellence Across Canada’s Biotechnology Ecosystem

GlobeNewswire28. aug. 2026, 20.01

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Simply Wall St.28. aug. 2026, 08.20

What Xenon Pharmaceuticals (XENE)'s New Azetukalner Phase 3 Epilepsy Data Means For Shareholders